SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-23-009608
Filing Date
2023-08-10
Accepted
2023-08-10 16:22:03
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_063023.htm   iXBRL 10-Q 943033
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 10482
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 10479
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-01.htm EX-32.01 3807
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-02.htm EX-32.02 3873
  Complete submission text file 0001387131-23-009608.txt   5881139

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tnxp-20230630.xsd EX-101.SCH 66046
7 XBRL CALCULATION FILE tnxp-20230630_cal.xml EX-101.CAL 73018
8 XBRL DEFINITION FILE tnxp-20230630_def.xml EX-101.DEF 252906
9 XBRL LABEL FILE tnxp-20230630_lab.xml EX-101.LAB 414827
10 XBRL PRESENTATION FILE tnxp-20230630_pre.xml EX-101.PRE 362095
86 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10q_063023_htm.xml XML 761772
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 231159880
SIC: 2834 Pharmaceutical Preparations